NCT04545463

Hypocholesterolemic Effect of Fibracep

Validation Study of the Effects of FIBRACEP Supplementation on the Lipid Profile

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Universitat de Lleida · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

FIBRACEP is an onion based fiber that has demonstrated in vitro and in animal models the capacity to increase HDL cholesterol levels as well to improve other lipid profile species. This intervention aims to demonstrate FIBRACEP's blood lipid profile improvement effect. For that purpose, hypercholesterolemic subjects will be recruited and given a daily dose of 7 g of FIBRACEP for two months. Changes in blood lipid profile will be the end-point of the study.

Conditions

• Hypercholesterolemia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	FIBRACEP	A total intake of 7 g/day of FIBRACEP (provided in 6 cookies of 15 g/each) during two months
DIETARY_SUPPLEMENT	INSOLUBLE	A total intake of 7 g/day of wheat bran (provided in 6 cookies of 15 g/each) during two months
DIETARY_SUPPLEMENT	SOLUBLE	A total intake of 7 g/day of psyllium plantago (provided in 6 cookies of 15g/each) during two months

Timeline

• Start date: 2015-05-01
• Primary completion: 2016-05-01
• Completion: 2016-05-01
• First posted: 2020-09-11
• Last updated: 2020-09-11

Locations

1 site across 1 country: Spain